The History of IgE: From Discovery to 2010
- 505 Downloads
The discovery of IgE and the role of IgE-mediated inflammation gave clinical allergy a scientific backbone, and as a result, the reputation of the specialty allergy has increased considerably over the years. Allergy diagnosis was improved by assays for in vitro determination of the presence and concentration of IgE antibodies, and clinical knowledge also broadened, allowing better service for the increasing number of allergic individuals. Access to immune assays for allergens finally allowed characterization and standardization of allergen preparations used for diagnosis and allergen-specific immunotherapy. Improved basic molecular technologies have further increased our knowledge about the complex component composition of an allergen extract, introduced IgE-specific immunotherapy, and allowed the allergist to better handle even severe allergic reactions such as anaphylaxis.
KeywordsIgE antibody ASIT ESIT CD-sens
No potential conflict of interest relevant to this article was reported.
Papers of particular interest, published recently, have been highlighted as: ••Of major importance
- 2.Ramirez MA: Horse asthma following blood transfusion: Report on a case. JAMA 1919, 73:984–985.Google Scholar
- 3.Prausnitz C, Küstner H: Studien über die Überempfindlichkeit. Zentralbl Bakteriol I Abt Orig 1921, 86:160–169.Google Scholar
- 4.Coca AF, Cooke RA: On the classification of the phenomenon of hypersensitiveness. J Immunol 1923, 8:163–182.Google Scholar
- 11.Bennich HH, Ishizaka K, Johansson SGO, et al.: Immunoglobulin E, a new class of human immunoglobulin. Bull World Health Organ 1968, 38:151–152.Google Scholar
- 13.Marsh DG: Allergens and the genetics of allergy. In: Sela M (ed.) The Antigens, vol. 3, Academic Press, New York, 1975, pp. 271–359.Google Scholar
- 16.Lindelöf B, Granath F, Tengvall-Linder M, Ekbom A: Allergy and cancer. Allergy 2005, 60:1116–1120.Google Scholar
- 29.•• Johansson SGO, Nopp A, Öman H, et al.: The size of the disease relevant IgE antibody fraction in relation to “total-IgE” predicts the efficacy of anti-IgE (Xolair®) treatment. Allergy 2009, 64:1472–1477. This study proofs that the dosage of anti-IgE must be linked to the size of the IgE antibody fraction. PubMedCrossRefGoogle Scholar
- 33.•• Johansson SGO, Bieber, T, Dahl R, et al.: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004, 113:832–836. Without one and the same nomenclature we cannot communicate.PubMedCrossRefGoogle Scholar